Is HRT Safe After 60? A Specialist’s Advice

For many women, the question is not whether menopause symptoms should have stopped by 60, but why they are still affecting sleep, mood, confidence, intimacy and day-to-day life. So, is HRT safe after 60? There is no single answer based on age alone. Safety depends on your symptoms, medical history, the type of HRT you use, when you started it and the quality of ongoing review.

HRT can remain an appropriate and effective treatment for some women over 60. Equally, it may not be suitable for everyone, and starting systemic HRT for the first time later in life requires a particularly careful, individual assessment. A specialist consultation creates space to look at the whole picture rather than making a decision from a date of birth alone.

Is HRT Safe After 60?

The short answer is that HRT is not automatically unsafe after 60, nor does every woman need to stop it simply because she has reached a particular age. Current menopause care is based on balancing likely benefits against individual risks, with treatment reviewed regularly.

This distinction matters because continuing HRT after 60 is not the same clinical decision as beginning it at 60 or beyond. A woman who started HRT around the time of menopause, is well and has had regular reviews may be able to continue treatment if the benefits remain meaningful. In contrast, someone considering systemic HRT for the first time many years after their last period may have a different cardiovascular and clotting risk profile to consider.

Specialists also look beyond hot flushes. Persistent night sweats, poor sleep, low mood, joint aches, brain fog, vaginal dryness, recurrent urinary symptoms and painful sex can have a significant effect on quality of life. The aim is not to prescribe HRT by default, but to make an informed, evidence-based choice that reflects what matters to you.

Why timing, formulation and health history matter

HRT is not one treatment. It includes different hormones, doses and routes of administration. These details can materially affect the risk-benefit discussion.

Oestrogen can be given through the skin as a patch, gel or spray, or taken as a tablet. Transdermal oestrogen is often preferred for women with certain risk factors because it does not have the same effect on clotting factors as oral oestrogen. It may therefore be a more suitable option for women with a raised risk of venous thromboembolism, migraine or particular metabolic concerns, although the right choice always depends on the individual.

If you have a uterus, systemic oestrogen needs to be paired with adequate progestogen to protect the lining of the womb. This may be provided as a tablet, capsule or hormonal coil, depending on your circumstances. The type and duration of combined HRT are relevant when discussing breast cancer risk, which should be considered in the context of your personal and family history rather than viewed in isolation.

A clinician will also consider whether you are still having periods, when your final period occurred, whether you have had a hysterectomy, and whether symptoms could have another explanation. Thyroid disease, iron deficiency, sleep apnoea, depression, medication side effects and other health conditions can overlap with menopause symptoms. Good care does not assume that every symptom is hormonal.

Starting HRT later versus continuing treatment

For women who begin systemic HRT closer to menopause, the overall balance of benefits and risks is often more favourable than for those who first start many years later. Beginning HRT after 60 can be appropriate in selected cases, but it needs a more detailed assessment of cardiovascular health and other risk factors.

HRT should not be started solely to prevent heart disease or dementia. However, this does not mean a woman over 60 with troublesome symptoms cannot be considered for treatment. It means the decision should be personalised, with clear discussion of what HRT is expected to help, what uncertainties exist and how treatment will be monitored.

If you are already using HRT and feeling well, stopping simply because you have reached 60 may not be necessary. Some women prefer to reduce or stop treatment, while others find symptoms return and decide that continued use offers worthwhile benefits. There is no universal deadline. Regular review allows the dose and formulation to be adjusted as your needs change.

When extra caution is needed

Some circumstances require specialist input before systemic HRT is considered. This does not always mean HRT is impossible, but it may mean that non-hormonal options, local treatment or a different formulation is safer.

Particular care is needed if you have a history of breast, ovarian or womb cancer; unexplained vaginal bleeding; blood clots; stroke; heart attack; active liver disease; or known clotting disorders. A strong family history of breast cancer, high blood pressure, diabetes, high cholesterol, obesity and smoking are also important parts of the assessment.

A previous cancer diagnosis can make the conversation feel especially difficult. The appropriate approach depends on the type of cancer, its hormone sensitivity, treatment history and the severity of menopausal symptoms. Decisions in this setting may involve your oncology team alongside a menopause specialist.

Vaginal oestrogen is different from systemic HRT. Low-dose local treatment for vaginal dryness, discomfort, urinary urgency or recurrent urinary tract infections has very low absorption into the bloodstream and can often be used long term. It is frequently an important option for women who cannot use systemic HRT, although those with a history of hormone-sensitive cancer should still seek personalised advice.

What a thorough HRT review after 60 should include

A safe review is more than a quick prescription check. It should explore both your current wellbeing and future health priorities. Depending on your history, your clinician may assess:

• your current symptoms, sleep, mood, sexual wellbeing and the practical benefit you get from treatment;

• the age you started HRT, your dose, route of oestrogen and the progestogen you use;

• blood pressure, weight, smoking status and personal or family history of cardiovascular disease, clots and cancer;

• bleeding patterns, cervical screening and breast screening status; and

• medicines, medical conditions and lifestyle factors that may change your risk over time.

Blood tests can be useful when symptoms are complex or another condition is suspected, but hormone blood levels do not usually determine whether HRT is needed or whether a dose is right. Menopause treatment is guided primarily by symptoms, clinical history and safety monitoring. This is particularly relevant after 60, when it is important not to overlook other causes of fatigue, low mood or changes in weight.

Making a confident, informed decision

It is understandable to feel concerned by headlines about HRT risks. The most useful question is not whether HRT is broadly “good” or “bad”, but what its likely benefits and risks are for you at this stage of life.

For some women, the gains are substantial: restored sleep, fewer flushes, less pain during sex, improved comfort and a greater sense of themselves again. For others, the potential risks, uncertainty or inconvenience mean non-hormonal treatment feels like the better path. Options may include cognitive behavioural therapy for menopause symptoms, targeted sleep support, vaginal moisturisers and lubricants, or prescription non-hormonal medicines where appropriate.

If you use HRT, arrange regular reviews and seek prompt medical advice about unexpected vaginal bleeding, chest pain, sudden breathlessness, a painful swollen leg, or new breast changes. These symptoms need assessment whether or not you use HRT.

Age should prompt a thoughtful conversation, not an automatic stop sign. With a careful assessment, the right formulation and ongoing specialist review, many women can make a treatment decision that supports both symptom control and long-term health. To discuss your individual circumstances, visit our consultations page and arrange time with a menopause specialist who will listen carefully to your goals and concerns.